Ashley McEvoy, President and Chief Executive Officer of Insulet Corporation, filed a statement of changes in beneficial ownership on August 24, 2026, reporting an open-market purchase of Insulet common stock transacted on August 21, 2026.

Key Highlights

  • Purchase transaction: Ashley McEvoy acquired 1,100 shares of Insulet Corporation common stock on August 21, 2026.
  • Weighted average price: Shares were purchased at a weighted average price of $147.47, with individual transaction prices ranging from $147.42 to $147.62.
  • Resulting ownership: Following the transaction, McEvoy directly beneficially owns 23,731 shares of common stock.
  • ESPP shares included: The 23,731 share total includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the reporting person's last filing.
  • Indirect holding: The filing also discloses 4 shares of common stock held indirectly by trust.
  • Reporting role: McEvoy is identified in the filing as both a Director and an Officer, serving as President and CEO.

Insulet CEO Ashley McEvoy Adds to Direct Stock Position in August 2026

According to the filing, Ashley McEvoy, who serves as President and Chief Executive Officer of Insulet Corporation (NASDAQ:PODD), purchased 1,100 shares of the company's common stock on August 21, 2026. The transaction was coded "P," indicating an open-market purchase. The filing reports a weighted average purchase price of $147.47 per share, with individual transactions executed at prices between $147.42 and $147.62. The filing states that McEvoy undertakes to provide full information regarding the number of shares purchased at each separate price upon request by SEC Staff, the issuer, or a security holder.

Insulet Corporation, headquartered at 100 Nagog Park, Acton, Massachusetts 01720, is the issuer of the shares reported in the filing. Following the reported purchase, the filing discloses that McEvoy directly beneficially owns 23,731 shares of Insulet common stock. That total, as noted in the filing, includes 80 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the reporting person's most recent prior filing. Separately, the filing records 4 shares held indirectly through a trust.

The filing was signed by Patricia K. Dolan as attorney-in-fact on August 24, 2026. No derivative securities transactions were reported in Table II of the filing. The filing was made by one reporting person and was not identified as an amendment to a prior filing.

What Was Disclosed

The filing reported an open-market purchase of 1,100 shares of Insulet Corporation common stock by President and CEO Ashley McEvoy on August 21, 2026, at a weighted average price of $147.47, bringing McEvoy's direct beneficial ownership to 23,731 shares.